LCTX
Price
$1.67
Change
-$0.03 (-1.76%)
Updated
Jan 15, 11:46 AM (EDT)
Capitalization
391.56M
49 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$6.58
Change
-$0.23 (-3.37%)
Updated
Jan 15, 12:21 PM (EDT)
Capitalization
948.14M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LCTX vs VIR

Header iconLCTX vs VIR Comparison
Open Charts LCTX vs VIRBanner chart's image
Lineage Cell Therapeutics
Price$1.67
Change-$0.03 (-1.76%)
Volume$300
Capitalization391.56M
Vir Biotechnology
Price$6.58
Change-$0.23 (-3.37%)
Volume$300
Capitalization948.14M
LCTX vs VIR Comparison Chart in %
View a ticker or compare two or three
VS
LCTX vs. VIR commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Hold and VIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (LCTX: $1.70 vs. VIR: $6.82)
Brand notoriety: LCTX and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 49% vs. VIR: 162%
Market capitalization -- LCTX: $391.56M vs. VIR: $948.14M
LCTX [@Biotechnology] is valued at $391.56M. VIR’s [@Biotechnology] market capitalization is $948.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, both LCTX and VIR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • LCTX’s TA Score: 4 bullish, 4 bearish.
  • VIR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VIR is a better buy in the short-term than LCTX.

Price Growth

LCTX (@Biotechnology) experienced а -7.10% price change this week, while VIR (@Biotechnology) price change was +10.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

LCTX is expected to report earnings on Mar 05, 2026.

VIR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($948M) has a higher market cap than LCTX($392M). VIR YTD gains are higher at: 13.101 vs. LCTX (1.796). LCTX has higher annual earnings (EBITDA): -19.68M vs. VIR (-541.01M). VIR has more cash in the bank: 507M vs. LCTX (40.5M). LCTX has less debt than VIR: LCTX (2.62M) vs VIR (100M). VIR has higher revenues than LCTX: VIR (14M) vs LCTX (10.8M).
LCTXVIRLCTX / VIR
Capitalization392M948M41%
EBITDA-19.68M-541.01M4%
Gain YTD1.79613.10114%
P/E RatioN/AN/A-
Revenue10.8M14M77%
Total Cash40.5M507M8%
Total Debt2.62M100M3%
FUNDAMENTALS RATINGS
LCTX vs VIR: Fundamental Ratings
LCTX
VIR
OUTLOOK RATING
1..100
6061
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
3861
P/E GROWTH RATING
1..100
6228
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VIR's Valuation (52) in the null industry is in the same range as LCTX (65). This means that VIR’s stock grew similarly to LCTX’s over the last 12 months.

VIR's Profit vs Risk Rating (100) in the null industry is in the same range as LCTX (100). This means that VIR’s stock grew similarly to LCTX’s over the last 12 months.

VIR's SMR Rating (97) in the null industry is in the same range as LCTX (99). This means that VIR’s stock grew similarly to LCTX’s over the last 12 months.

LCTX's Price Growth Rating (38) in the null industry is in the same range as VIR (61). This means that LCTX’s stock grew similarly to VIR’s over the last 12 months.

VIR's P/E Growth Rating (28) in the null industry is somewhat better than the same rating for LCTX (62). This means that VIR’s stock grew somewhat faster than LCTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXVIR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
LCTX
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJEQX15.980.09
+0.57%
PGIM US Real Estate R6
PEIZX24.36N/A
N/A
PGIM Jennison Value Z
BBTLX16.97-0.10
-0.59%
Bridge Builder Tax Managed Large Cap
DGYGX35.46-0.22
-0.62%
BNY Mellon Appreciation Y
LIMIX7.66-0.07
-0.91%
Cromwell Tran Sustainable Focus Instl

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+1.80%
MDGL - LCTX
43%
Loosely correlated
+2.29%
ABCL - LCTX
39%
Loosely correlated
+0.47%
CRSP - LCTX
37%
Loosely correlated
+1.26%
RXRX - LCTX
36%
Loosely correlated
+3.41%
VIR - LCTX
36%
Loosely correlated
+8.08%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been closely correlated with SANA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+8.08%
SANA - VIR
69%
Closely correlated
+0.85%
XNCR - VIR
54%
Loosely correlated
+3.66%
XENE - VIR
52%
Loosely correlated
+3.02%
NUVL - VIR
52%
Loosely correlated
+6.59%
CRBU - VIR
51%
Loosely correlated
+1.26%
More